Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Schering-Plough initiates phase I with oral antithrombotic

June 25, 1998

BioChem Pharma describes lactams for thrombotic disorders

June 23, 1998

Eisai launches monteplase in first market

June 16, 1998

Bayer seeks FDA approval for improved second-generation hemophilia A product

June 12, 1998

Targeted NO donor enhances the activity of aspirin and heparin in preventing embolization

June 8, 1998

Avigen and Cell Genesys report success with gene therapy of hemophilia B

June 2, 1998

Emisphere Technologies begins phase II trial with oral heparin

June 1, 1998

Integrilin launched in first market today

June 1, 1998

Schering AG presents factor Xa/thrombin inhibitors

June 1, 1998

New antiplatelet agents prepared by Sankyo/Ube researchers

May 29, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...